These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 933105

  • 1. Midtrimester pregnancy termination with prostaglandin E2 vaginal suppositories.
    Hochman M, Laufe LE.
    J Reprod Med; 1976 May; 16(5):263-8. PubMed ID: 933105
    [Abstract] [Full Text] [Related]

  • 2. Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositories.
    Southern EM, Gutknecht GD.
    Obstet Gynecol; 1976 May; 47(5):602-6. PubMed ID: 1264407
    [Abstract] [Full Text] [Related]

  • 3. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
    Robins J, Surrago EJ.
    J Reprod Med; 1982 Jul; 27(7):415-9. PubMed ID: 6956734
    [Abstract] [Full Text] [Related]

  • 4. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
    Lauersen NH, Wilson KH.
    Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
    [Abstract] [Full Text] [Related]

  • 5. Vaginally administered prostaglandin E2 as a first and second trimester abortifacient.
    Corson SL, Bolognese RJ.
    J Reprod Med; 1975 Feb; 14(2):43-6. PubMed ID: 1113258
    [Abstract] [Full Text] [Related]

  • 6. Prostaglandin E2 vaginal suppositories for therapeutic abortion.
    Newman C, Bailey CD, Ellinas SP, Anderson GG.
    Adv Plan Parent; 1975 Feb; 10(1):34-8. PubMed ID: 1164986
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Association of extrauterine fetal death with failure of prostaglandin E2 suppositories.
    Orr JW, Huddleston JF, Goldenberg RL, Knox GE, Davis RO.
    Obstet Gynecol; 1979 Mar; 53(3 Suppl):56S-58S. PubMed ID: 424129
    [Abstract] [Full Text] [Related]

  • 10. Prostaglandin E2 suppositories as a second-trimester abortifacient.
    Rakhshani R, Grimes DA.
    J Reprod Med; 1988 Oct; 33(10):817-20. PubMed ID: 3193412
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The use of prostaglandins and their analogues for abortion.
    Bygdeman M.
    Clin Obstet Gynaecol; 1984 Dec; 11(3):573-84. PubMed ID: 6391777
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Second-trimester pregnancy termination: comparison of three different methods.
    Makhlouf AM, Al-Hussaini TK, Habib DM, Makarem MH.
    J Obstet Gynaecol; 2003 Jul; 23(4):407-11. PubMed ID: 12881083
    [Abstract] [Full Text] [Related]

  • 17. Preabortion cervical dilatation with a low-dose prostaglandin suppository. A comparison of two analogs.
    Lauersen NH, Graves ZR.
    J Reprod Med; 1984 Feb; 29(2):133-5. PubMed ID: 6708030
    [Abstract] [Full Text] [Related]

  • 18. Midtrimester pregnancy termination by intravaginal administration of prostaglandin E2.
    Surrago EJ, Robins J.
    Contraception; 1982 Sep; 26(3):285-94. PubMed ID: 6756775
    [Abstract] [Full Text] [Related]

  • 19. Laminaria augmentation of midtrimester pregnancy termination by intramuscular prostaglandin 15 (S) 15-methyl F2 alpha.
    Robins J, Mann LI.
    J Reprod Med; 1976 Jun; 16(6):334-6. PubMed ID: 957359
    [Abstract] [Full Text] [Related]

  • 20. Comparison of two prostaglandins used to terminate midtrimester pregnancy.
    Gookin KS, White CK, Whitworth NS, Wiser WL, Morrison JC.
    South Med J; 1984 Jun; 77(6):717-8, 721. PubMed ID: 6587588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.